ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,042, issued on Oct. 14, was assigned to Agency for Science, Technology and Research (Singapore).
"Epigenomic profiling reveals the somatic promoter landscape of primary gastric adenocarcinoma" was invented by Patrick Tan (Singapore), Aditi Qamra (Singapore), Manjie Xing (Singapore) and Wen Fong Ooi (Singapore).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for determining the presence or absence of at least one promoter in a cancerous biological sample relative to a non-cancerous biological sample. The present invention also relates to a method for determining the prognosis of cancer in a subject, a method fo...